新冠肺炎危机时期癌症患者静脉化疗依从性分析

IF 0.3 4区医学 Q4 ONCOLOGY

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi Pub Date : 2020-09-30 DOI:10.4999/UHOD.204528

I. Beypınar, M. Urun

{"title":"新冠肺炎危机时期癌症患者静脉化疗依从性分析","authors":"I. Beypınar, M. Urun","doi":"10.4999/UHOD.204528","DOIUrl":null,"url":null,"abstract":"SARS-CoV-2 is a single-stranded RNA spherical virus spikes formed by glycoproteins The leading cause of death was linked to acute respiratory distress syndrome, myocardial injury, or renal failure After the first case reported on the 11th of March in Turkey Ministry of Health and Interior declared some regulations on the public, such as travel restrictions, traffic restrictions, social distancing homes, and centralized quarantine Although chemotherapy adherence is a highly studied area for both oral and intravenous agents in cancer patients, no available data exist in a pandemic world with many social restrictions The records of patients who have active cancer treatment in the department of medical oncology retrospectively analyzed The age, gender, diagnosis, chemotherapy type, rendezvous, and coming dates recorded Four chemotherapy delays (3 7%) were observed out of 52 patients before the 11th of March 2020, while 43 chemotherapy delays (39,8%9) occurred out of 107 patients after the first COVID-19 case and the restrictions in Turkey Twenty patients had treatment delay without reason and did not show up for treatment on the day of chemotherapy The treatment delays without reasons are significantly different in the pre and post COVID-19 pandemic era The hematologic toxicity rates were similar when compared pre and post COVID-19 period The non-specific regulations and declarations confuse the patients and prevent them from reaching the treatment which is needed In the case of pandemic regulations, oncologic patients may have special considerations for government decisions © 2020, UHOD - Uluslararasi Hematoloji Onkoloji Dergisi All rights reserved","PeriodicalId":49402,"journal":{"name":"Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2020-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":"{\"title\":\"Intravenous Chemotherapy Adherence of Cancer Patients in Time of Covid-19 Crisis\",\"authors\":\"I. Beypınar, M. Urun\",\"doi\":\"10.4999/UHOD.204528\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"SARS-CoV-2 is a single-stranded RNA spherical virus spikes formed by glycoproteins The leading cause of death was linked to acute respiratory distress syndrome, myocardial injury, or renal failure After the first case reported on the 11th of March in Turkey Ministry of Health and Interior declared some regulations on the public, such as travel restrictions, traffic restrictions, social distancing homes, and centralized quarantine Although chemotherapy adherence is a highly studied area for both oral and intravenous agents in cancer patients, no available data exist in a pandemic world with many social restrictions The records of patients who have active cancer treatment in the department of medical oncology retrospectively analyzed The age, gender, diagnosis, chemotherapy type, rendezvous, and coming dates recorded Four chemotherapy delays (3 7%) were observed out of 52 patients before the 11th of March 2020, while 43 chemotherapy delays (39,8%9) occurred out of 107 patients after the first COVID-19 case and the restrictions in Turkey Twenty patients had treatment delay without reason and did not show up for treatment on the day of chemotherapy The treatment delays without reasons are significantly different in the pre and post COVID-19 pandemic era The hematologic toxicity rates were similar when compared pre and post COVID-19 period The non-specific regulations and declarations confuse the patients and prevent them from reaching the treatment which is needed In the case of pandemic regulations, oncologic patients may have special considerations for government decisions © 2020, UHOD - Uluslararasi Hematoloji Onkoloji Dergisi All rights reserved\",\"PeriodicalId\":49402,\"journal\":{\"name\":\"Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2020-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4999/UHOD.204528\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4999/UHOD.204528","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 10

摘要

SARS-CoV-2是一种由糖蛋白形成的单链RNA球形病毒尖峰，其主要死因与急性呼吸窘迫综合征、心肌损伤或肾衰竭有关。3月11日土耳其报告了第一例病例后，卫生部和内政部宣布了一些针对公众的规定，如旅行限制、交通限制、保持社交距离、尽管对癌症患者的口服和静脉化疗依从性进行了高度研究，但在大流行的世界中，没有可用的数据，而且有许多社会限制。回顾性分析了肿瘤内科积极接受癌症治疗的患者的记录，包括年龄、性别、诊断、化疗类型、地点、在2020年3月11日之前，52名患者中观察到4名化疗延迟(3.7%)，107例患者中有43例(39.8%)出现化疗延迟，20例患者出现治疗无故延迟，化疗当日未到治疗，在COVID-19大流行前后治疗无故延迟有显著差异，与COVID-19前后相比，血液学毒性率相似，非特异性规定和声明使患者感到困惑并阻止他们获得所需的治疗在大流行法规的情况下，肿瘤患者可能对政府的决定有特殊考虑©2020,UHOD - Uluslararasi Hematoloji Onkoloji Dergisi版权所有

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Intravenous Chemotherapy Adherence of Cancer Patients in Time of Covid-19 Crisis

SARS-CoV-2 is a single-stranded RNA spherical virus spikes formed by glycoproteins The leading cause of death was linked to acute respiratory distress syndrome, myocardial injury, or renal failure After the first case reported on the 11th of March in Turkey Ministry of Health and Interior declared some regulations on the public, such as travel restrictions, traffic restrictions, social distancing homes, and centralized quarantine Although chemotherapy adherence is a highly studied area for both oral and intravenous agents in cancer patients, no available data exist in a pandemic world with many social restrictions The records of patients who have active cancer treatment in the department of medical oncology retrospectively analyzed The age, gender, diagnosis, chemotherapy type, rendezvous, and coming dates recorded Four chemotherapy delays (3 7%) were observed out of 52 patients before the 11th of March 2020, while 43 chemotherapy delays (39,8%9) occurred out of 107 patients after the first COVID-19 case and the restrictions in Turkey Twenty patients had treatment delay without reason and did not show up for treatment on the day of chemotherapy The treatment delays without reasons are significantly different in the pre and post COVID-19 pandemic era The hematologic toxicity rates were similar when compared pre and post COVID-19 period The non-specific regulations and declarations confuse the patients and prevent them from reaching the treatment which is needed In the case of pandemic regulations, oncologic patients may have special considerations for government decisions © 2020, UHOD - Uluslararasi Hematoloji Onkoloji Dergisi All rights reserved

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi ONCOLOGY-

CiteScore

1.60

自引率

16.70%

发文量

审稿时长

>12 weeks

期刊介绍： Target of Publication is the public representation of new scientific results of fundamental, problem-oriented, and search scientific investigations; analytical articles and reviews by actual scientific problems of coal mining industry, short reports in the field of coal mining industry, including the results of work of scientific meetings, conferences, summit’s and congresses in the field of mining. The basic purpose of the journal is the promotion of innovative activity in the coal mining industry by highlighting and discussing the results of basic and applied research, the experience in applying results of innovation for the development of the Russian coal mining. The most important tasks of the journal are: the generalization of scientific and practical achievements of specialists in the field of coal mining industry, specializing in the implementation of promising basic and applied research and development of priorities of high technologies; the scientific concept of the publication; the publication of the latest achievements in the field of innovation in coal mining industry. The journal lays special emphasis on methodical elaborations, analytical investigations in the sphere of coal mining. Targets of Journal are in publication of new results of scientific investigations performed by scientists, post-graduate students, and doctoral candidates performed by from higher schools, Russian Academy of Sciences, other scientific organizations of Russia, CIS countries, and foreign universities